These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

989 related items for PubMed ID: 31094571

  • 1. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
    Rukmangathen R, Yallamalli IM, Yalavarthi PR.
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
    [Abstract] [Full Text] [Related]

  • 2. Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease.
    Rukmangathen R, Yallamalli IM, Yalavarthi PR.
    Curr Drug Discov Technol; 2019 Aug; 16(4):417-425. PubMed ID: 29669501
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP, Jain K, Jain NK.
    Int J Pharm; 2013 Nov 01; 456(1):31-40. PubMed ID: 23994363
    [Abstract] [Full Text] [Related]

  • 7. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.
    Wang X, Chi N, Tang X.
    Eur J Pharm Biopharm; 2008 Nov 01; 70(3):735-40. PubMed ID: 18684400
    [Abstract] [Full Text] [Related]

  • 8. Quantification and Brain Targeting of Eugenol-Loaded Surface Modified Nanoparticles Through Intranasal Route in the Treatment of Cerebral Ischemia.
    Ahmad N, Ahmad R, Alam MA, Ahmad FJ.
    Drug Res (Stuttg); 2018 Oct 01; 68(10):584-595. PubMed ID: 29669380
    [Abstract] [Full Text] [Related]

  • 9. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
    Fazil M, Md S, Haque S, Kumar M, Baboota S, Sahni JK, Ali J.
    Eur J Pharm Sci; 2012 Aug 30; 47(1):6-15. PubMed ID: 22561106
    [Abstract] [Full Text] [Related]

  • 10. Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain.
    Hanafy AS, Farid RM, ElGamal SS.
    Drug Dev Ind Pharm; 2015 Aug 30; 41(12):2055-68. PubMed ID: 26133084
    [Abstract] [Full Text] [Related]

  • 11. Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer's disease in intracerebroventricular streptozotocin model for brain delivery.
    Zameer S, Ali J, Vohora D, Najmi AK, Akhtar M.
    J Drug Target; 2021 Feb 30; 29(2):199-216. PubMed ID: 32876502
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Preparation and characterization of insulin chitosan-nanoparticles loaded in buccal films.
    Al-Nemrawi NK, Alsharif SSM, Alzoubi KH, Alkhatib RQ.
    Pharm Dev Technol; 2019 Oct 30; 24(8):967-974. PubMed ID: 31092092
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preparation of Chitosan Okra Nanoparticles: Optimization and Evaluation as Mucoadhesive Drug Delivery System.
    Brar V, Kaur G.
    Pharm Nanotechnol; 2018 Oct 30; 6(3):180-191. PubMed ID: 30101724
    [Abstract] [Full Text] [Related]

  • 17. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
    Md S, Khan RA, Mustafa G, Chuttani K, Baboota S, Sahni JK, Ali J.
    Eur J Pharm Sci; 2013 Feb 14; 48(3):393-405. PubMed ID: 23266466
    [Abstract] [Full Text] [Related]

  • 18. Understanding the role of colon-specific microparticles based on retrograded starch/pectin in the delivery of chitosan nanoparticles along the gastrointestinal tract.
    Dos Santos AM, Meneguin AB, Akhter DT, Fletcher N, Houston ZH, Bell C, Thurecht KJ, Gremião MPD.
    Eur J Pharm Biopharm; 2021 Jan 14; 158():371-378. PubMed ID: 33309846
    [Abstract] [Full Text] [Related]

  • 19. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study.
    Delan WK, Zakaria M, Elsaadany B, ElMeshad AN, Mamdouh W, Fares AR.
    Int J Pharm; 2020 Mar 15; 577():119038. PubMed ID: 31953085
    [Abstract] [Full Text] [Related]

  • 20. Intranasal delivery of tapentadol hydrochloride-loaded chitosan nanoparticles: formulation, characterisation and its in vivo evaluation.
    Javia A, Thakkar H.
    J Microencapsul; 2017 Nov 15; 34(7):644-658. PubMed ID: 28862072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.